Katharine A. Price

TL;DR: Different PD-1 and PD-L1 inhibitors appear to have varying treatment-related adverse events; a comprehensive summary of the incidences of treatment- related adverse events in clinical trials provides an important guide for clinicians.

TL;DR: Combination platinum regimens increase response rates and toxicity but not survival and should be reserved for patients who are symptomatic from their disease for whom the benefit of a partial response may be worth the cost of increased treatment-related side effects.

TL;DR: Aggressive RT de-escalation resulted in locoregional tumor control rates comparable to historical controls, low toxicity, and little decrement in swallowing function or QOL.

TL;DR: In this article, the authors proposed that functional imaging could identify patients who could be safely deescalated to 30 Gy of radiotherapy by using a combination of magnetic resonance imaging (weekly), circulating plasma cell-free DNA, RNA-sequencing, and whole-genome sequencing (WGS).

TL;DR: In this paper, the outcomes of patients with locally-advanced HPV-negative HNSCC and HPV/p16-positive oropharynx cancer treated with adjuvant chemoradiation therapy with either high-dose or weekly cisplatin were compared.